Search - tctmd.com

Displaying 661 - 680 of 714

Sort: Relevancy | Date

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

Poor Association Between Stent Thrombosis, Platelet Function Tests

L.A. McKeown

July 26, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

After GRAVITAS: Is There a Future for Functional Platelet Testing?

July 18, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

Statin Users Have Better Outcomes After PCI for Stable CAD

L.A. McKeown

July 08, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Daily News

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

L.A. McKeown

June 17, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

Advertisement

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

ESC Congress 2011: Drugs, Devices Work Together

Halting Clopidogrel in First Year Following Acute MI Hazardous

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Long-term Antiplatelet Therapy: All Risk, No Benefit

Poor Association Between Stent Thrombosis, Platelet Function Tests

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

After GRAVITAS: Is There a Future for Functional Platelet Testing?

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Statin Users Have Better Outcomes After PCI for Stable CAD

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content